Abstract:New thalidomide analogs have been designed and synthesized by hybridizing the immunomodulatory gutarimide moiety with three antiproliferative nuclei: quinazolinedione, phthalazinedione, and quinoxalinone. The biological results revealed the strong impact of quinazoline derivatives 7a and 28, and phthalazine based 20a against HepG‐2, MCF‐7, PC3, and HCT‐116 cell lines, compared to thalidomide. In particular, compound 20a was the most promising as it had far better biological activity than thalidomide with regard to inhibition of TNF‐α, IL‐6, caspase 3, COX‐I/II, and VEGFR‐2, as well as cell cycle arrest, and apoptosis rate enhancement in MCF‐7 cells, the most sensitive cell line to the current new molecules. Compound 20a caused reduction in levels of TNF‐α and IL‐6 by 75.22% and 82.51%, respectively. It elevated the caspase‐3 level by 7.21‐fold. Furthermore, IC50 against COX‐I, COX‐II, and VEGFR‐2 were 0.65 μM, 0.33 μM, and 232 nM, respectively. In addition, it raised the apoptosis rate from 65.65% to 99.89%. Moreover, 20a was further examined through a docking study and a 200 ns molecular dynamics simulation for its complex with VEGFR‐2, along with computational ADME properties. This work suggests the high significance of compounds 20a, 7a and 28, as lead compounds for development of new effective immunomodulatory antitumor drugs.

Synthesis and Bioactivity of Novel Phthalimide Derivatives

Synthesis and Biological Evaluation of Novel Thalidomide Analogues As Potential Anticancer Drugs

Synthesis and Primary Anti-tumor Activities of 3-Fluoro-or 3-Amino-6-substituted-5,6-dihydropyrrolo [3,4-b] pyridin-7-ones

Synthesis and biological evaluation of nitric oxide-donating thalidomide analogues as anticancer agents.

Synthesis and Biological Evaluation of Thalidomide Derivatives as Potential Anti-Psoriasis Agents

Synthesis and Biological Activities of 3-Methoxy-6-substituted-5,6-dihydropyrrolo[3,4-b]pyridin-7-ones

New immunomodulatory anticancer quinazolinone-based thalidomide analogs: design, synthesis and biological evaluation

Discovery of New Immunomodulatory Anticancer Thalidomide Analogs: Design, Synthesis, Biological Evaluation and In Silico Studies

[Synthesis of 1,3-Dihydro-1,3-dioxo-2h-isoindole Derivatives].

Synthesis and Antiproliferative Activity of Novel 1,3,4-Thiadiazole Derivatives

One-step synthesis of thalidomide and its important derivatives

Synthesis and Biological Activity of 1,3,4-Thiadiazole Aroylurea Derivatives

Novel phthalide derivatives: Synthesis and anti-inflammatory activity in vitro and in vivo

Synthesis and in vitro study of pyrimidine-phthalimide hybrids as VEGFR2 inhibitors with antiproliferative activity

Synthesis and Antiproliferative Activity of Thiadiazole Peptidomimetic Derivatives

Synthesis, X-Ray Crystal Structure and Biological Activities of α-Phenoxy-1,2,3-thiadiazoleacetamide.

Synthesis and Bioactivity of 2-Amino-5[(2-chloropyrid)-4-yl]-1,3,4-thiadiazole Derivatives

New Phthalide Derivatives from the Biscogniauxia Sp. and Their Activities.

Synthesis and anti-inflammatory activity evaluation of a novel series of 6-phenoxy-[1,2,4]triazolo[3,4-a]phthalazine-3-carboxamide derivatives.

Synthesis and Identification of Some New Heterocyclic Compounds Derived from N-(6-Hydrazinyl-6-oxohexanoyl)phthalimide

Synthesis And Anti-Inflammatory Activity Evaluation Of Some Novel 6-Alkoxy (Phenoxy)-[1,2,4]Triazolo[3,4-A]Phthalazine-3-Amine Derivatives